miR-122-3p targets UBE2I to regulate the immunosuppression of liver cancer and the intervention of Liujunzi formula.

MLA

Guo, Zhenhui, et al. “MiR-122-3p Targets UBE2I to Regulate the Immunosuppression of Liver Cancer and the Intervention of Liujunzi Formula.” Journal of Ethnopharmacology, vol. 329, July 2024, p. 118081. EBSCOhost, https://doi.org/10.1016/j.jep.2024.118081.

APA

Guo, Z., Wang, Y., Qin, W., Heng, Y., Chen, X., Liu, N., Li, J., Wu, H., Zhou, Y., Zhang, R., Song, S., & Wu, Z. (2024). miR-122-3p targets UBE2I to regulate the immunosuppression of liver cancer and the intervention of Liujunzi formula. Journal of Ethnopharmacology, 329, 118081. https://doi.org/10.1016/j.jep.2024.118081

Chicago

Guo, Zhenhui, Yiqi Wang, Wanting Qin, Yin Heng, Xi Chen, Na Liu, Jinzhe Li, et al. 2024. “MiR-122-3p Targets UBE2I to Regulate the Immunosuppression of Liver Cancer and the Intervention of Liujunzi Formula.” Journal of Ethnopharmacology 329 (July): 118081. doi:10.1016/j.jep.2024.118081.